Nitric Oxide: The Missing Factor in COVID-19 Severity?

Med Sci (Basel). 2021 Dec 23;10(1):3. doi: 10.3390/medsci10010003.

Abstract

Coronavirus disease 2019 (COVID-19) is a contagious respiratory and vascular disease that continues to spread among people around the world, mutating into new strains with increased transmission rates, such as the delta variant. The scientific community is struggling to discover the link between negative COVID-19 outcomes in patients with preexisting conditions, as well as identify the cause of the negative clinical patient outcomes (patients who need medical attention, including hospitalization) in what seems like a widespread range of COVID-19 symptoms that manifest atypically to any preexisting respiratory tract infectious diseases known so far. Having successfully developed a nutritional formulation intervention based on nitrate, a nitric oxide precursor, the authors hypothesis is that both the comorbidities associated with negative clinical patient outcomes and symptoms associated with COVID-19 sickness are linked to the depletion of a simple molecule: nitric oxide.

Keywords: COVID-19; NO; SARS-CoV-2; comorbidities; etiology; nitric oxide.

MeSH terms

  • COVID-19 / metabolism*
  • COVID-19 / pathology
  • COVID-19 / physiopathology*
  • Humans
  • Nitric Oxide / metabolism*
  • SARS-CoV-2 / pathogenicity*
  • Severity of Illness Index

Substances

  • Nitric Oxide

Supplementary concepts

  • SARS-CoV-2 variants